Tango Therapeutics, Inc. — SCHEDULE 13D/A Filings
4 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Tango Therapeutics, Inc. (TNGX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tango Therapeutics, Inc. has filed 4 SCHEDULE 13D/A documents with the SEC since 2020. To view all SEC filings by Tango Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001193125-26-044719 | Feb 10, 2026 | — |
| SCHEDULE 13D/A | — | 0001193125-25-291391 | Nov 21, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-282980 | Nov 14, 2025 | — |
| SCHEDULE 13D/A | — | 0000895345-25-000001 | Jan 2, 2025 | — |